香川大学医学部薬理学

2014 学会発表等(国際)~Publications(International)~

(Pro)renin receptor is crucial for Wnt/β-cathenin-dependent genesis of pancreatic ductal adenocarcinoma.
Nishiyama A, Shibayama Y. Gordon Research Conference, The renin-Angiotensin System Beyond Angiotensin II. Mar. 2014. Lucca
 2
Suppression of insulin resistance by renal sympathetic denervation in obese rats.
Nishiyama A, Rafiq K. 8th International Congress on Uremia Research and Toxicity. Mar. 2014. Okinawa
 3
Extra-renal effect of RAAS Blockade
Nishiyama A. 8th International Congress on Uremia Research and Toxicity. Mar. 2014. Okinawa
 4
Pharmacological Impacts of GLP-1 Analogues and DPP-4 Inhibitors on Their Cardiovascular Protective Effects
Nishiyama A. 8th International Congress on Uremia Research and Toxicity. Mar. 2014. Okinawa
 5
Multiphoton imaging of microcirculation in the septic kidney.
Nakano D, Nishiyama A. The 18th International Vascular Biology Meeting. Apr. 2014. Kyoto
 6
Effects of a SGLT2 inhibitor empagliflozin, on blood pressure and urinary excretion of sodium in salt-treated metabolic syndrome rats.
Takeshige Y,Fujisawa Y, Sufiun A, Rahman A, Rafiq K, Nakano D, Ogata H. The 14th Asian Pacific Congress of Nephrology. May. 2014. Tokyo
 7
Effects of renal sympathetic denervation on blood pressure andglucose metabolism in obese type 2 diabetic rats.
Rafiq K, Sherajee S, Fujisawa Y, Mogi M, Sufiun A, Rahman A, Nakano D, Koepsell H, Nishiyama A. The 14th Asian Pacific Congress of Nephrology. May. 2014. Tokyo
 8
The efficacy and safety of febuxostat in the treatment of post-transplant hyperuricemia in stable kidney transplant recipients.
Sofue T, inui M, Hara T, Nishijima Y, Moriwaki K, Hayashida Y, Ueda N, Nishiyama A, kakehi Y, Kohno M. The 14th Asian Pacific Congress of Nephrology. May. 2014. Tokyo
 9
Effects of alogliptin on urinary excretion rates of albumin and angiotensinogen in patients with type 2 diabetes.
Mizushige T, Kobori H, Nishijima Y, Nishiyama A. The 14th Asian Pacific Congress of Nephrology. May. 2014. Tokyo
 10
Effects of high salt and renal denervation on blood pressure and dipping pattern in rats treated with adenine.
Sufiun A, Rahman A, Kitada K, Fujisawa Y, Nakano D, Rafiq K, Nishiyama A. The 14th Asian Pacific Congress of Nephrology. May. 2014. Tokyo
 11
Effect of a direct renin inhibitor on blood pressure and renin-angiotensin system in a patient with renovascular hypertension.
Kishida M, Nishiyama A, Hamada M, Shibata M, Kitabayashi C, Morikawa T, Konishi Y, Arai Y, Ichihara A, Kobori H, Imanishi M. The 14th Asian Pacific Congress of Nephrology. May. 2014. Tokyo
 12
Circadian rhythm of angiotensinogen levels in the plasma and urine of patients with chronic kidney disease.
Nishijima Y, Kobori H, Mizushige T, Hara T, Kohno M, Nishiyama A. The 14th Asian Pacific Congress of Nephrology. May. 2014. Tokyo
 13
Effects of erythropoietin originated by human ips cell-derived erythropoietin producing cells on adenine-induced renal anemia in mice.
Rahman M, Hitomi H, Osafune K, Nishiyama A. The 14th Asian Pacific Congress of Nephrology. May. 2014. Tokyo
 14
Effect of vildagliptin, a dpp-4 inhibitor, on blood pressure and dippiping pattern in dahl salt-sensitive rats.
Sufiun A, Fujisawa Y, Rahman A, Nakano D, Rafiq K, Kobori H, Nishiyama A. The 14th Asian Pacific Congress of Nephrology. May. 2014. Tokyo
 15
Renal sympathetic denervation suppresses insulin resistance in pre-diabetic obese oletf rats.
Rafiq K, Sherajee S, Fujisawa Y, Mogi M, Rahman A, Sufiun A, Nakano D, Koepsell H, Nishiyama A. The 14th Asian Pacific Congress of Nephrology. May. 2014. Tokyo
 16
Effects of vildagliptin on blood pressure and dipping pattern in Dahl salt-sensitive rats.
Nishiyama A, Fujisawa Y, Rahman A, Nakano D, Kobori H, Rafiq K, Sufiun A.. International Society of Hypertension. June. 2014. Athens
 17
Renal sympathetic denervation improves glucose metabolism through an activation of sodium dependent glucose transporter 2 in type 2 diabetic rats
Nishiyama A, Fujisawa Y, Rahman A, Mogi M, Sufiun A, Rafiq K.. International Society of Hypertension. June. 2014. Athens
 18
Effects of Diuretics on Sglt2 Inhibitor-induced Changes in Urinary Sodium Excretion Rate In Obese Metabolic Syndrome Rats.
Nishiyama A, Fujisawa Y, Sufiun A, Rafiq K, Nakano D, Kobori H, Rahman A. High Blood Pressure Research. Sep. 2014. San Francisco
 19
Effect of Dipeptidyl Peptidase-4 Inhibition on Blood Pressure and its Dipping Pattern in Dahl Salt-Sensitive Rats.
Nishiyama A, Fujisawa Y, Sufiun A, Rafiq K, Nakano D, Kobori H, Rahman A. . .
 20
Role of the renal sympathetic nerve in renal glucose metabolism during the development of type 2 diabetes in rats.
Rafiq K, Fujisawa Y, Nishiyama A.. ISN NEXUS Symposium Hypertension and Kidney. Sep. 2014. Brisbane
 21
Effect of diuretics on SGLT2 inhibitor-induced natriuresis in obese metabolic syndrome rats.
Rahman A, Nishiyama A.. ISN NEXUS Symposium Hypertension and Kidney. Sep. 2014. Brisbane
 22
Effects of the SGLT2 inhibitor, empagliflozin, on blood pressure and its circadian pattern in salt-treated obese rats.
Takeshige Y, Nishiyama A.. ISN NEXUS Symposium Hypertension and Kidney. Sep. 2014. Brisbane
 23
Effect of SGLT2 inhibitors on circadian blood pressure in metabolic syndrome.
Nishiyama A.. ISN NEXUS Symposium Hypertension and Kidney. Sep. 2014. Brisbane
 24
Reduction of Tubular Flow Rate as a Mechanism of Oliguria in Endotoxemia Revealed by Intravital Imaging
Nakano D, Doi K, Kuwabara T, Mori K, Masashi Mukoyama M, Nishiyama A.. American Society of Nepjrology, Kidney week 2014. Nov. 2014. Philadelphia
 25
Different mechanisms of acute versus long-term antihypertensive effects of soluble epoxide hydrolase inhibition: Studies in Cyp1a1-Ren-2 transgenic rats.
Alexandra Sporkova, Sarka Jichova, Zuzana Huskova, Libor Kopkan, Akira Nishiyama, Sung H. Hwang, Bruce D. Hammock, John D. Imig, Elzbieta Kompanowska-Jezierska, Janusz Sadowski, Herbert J. Kramer, Ludek Cervenka. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY. Dec. 2014.
 26
Circadian rhythm of plasma and urinary angiotensinogen in healthy volunteers and in patients with chronic kidney disease.
Yoko Nishijima, Hiroyuki Kobori, Kumiko Kaifu, Tomoko Mizushige, Taiga Hara, Akira Nishiyama, Masakazu Kohno. Journal of the renin-angiotensin-aldosterone system : JRAAS. Dec. 2014.
 27
Measurement of the Mid-infrared Fourier Spectroscopic Imaging of Whole Human Face by Portable Apparatus (Size: 50*50mm, Weight: 200g)
Wei Qi, Yo Suzuki, Masaru Fujiwara, Tsubasa Saito, Satoru Suzuki, Pradeep Kumara Abeygunawardhana, Kenji Wada, Akira Nishiyama, Ichiro Ishimaru. OPTICS IN HEALTH CARE AND BIOMEDICAL OPTICS VI 9268. Nov. 2014.
 28
Quantitative measurement of biological substances in daily-life environment with the little-finger-size one-shot spectroscopic tomography
Akane Ishida, Shun Sato, Sho Nakada, Satoru Suzuki, P. K. W. Abeygunawardhana, Kenji Wada, Akira Nishiyama, Ichiro Ishimaru. OPTICAL DIAGNOSTICS AND SENSING XIV: TOWARD POINT-OF-CARE DIAGNOSTICS 8951. Feb. 2014.
 29
Wide-field spectroscopic imaging of biological-substance distributions on entire faces by measuring middle infrared lights emitted from human bodies itself
Yo Suzuki, Wei Qi, Masaru Fujiwara, Hiroyuki Hiramatsu, Satoru Suzuki, Pradeep Abeygunawardhana, Kenji Wada, Akira Nishiyama, Ichirou Ishimaru. OPTICAL DIAGNOSTICS AND SENSING XIV: TOWARD POINT-OF-CARE DIAGNOSTICS 8951. Feb. 2014.
 30
RENOPROTECTIVE EFFECTS OF COMBINING RAS BLOCKADE DRUGS WITH SPIRONOLACTONE IN PATIENTS WITH DIABETIC MEPHROPATHY AND OVERT ALBUMINURIA
Sawako Kato, Shoichi Maruyama, Hirofumi Makino, Jun Wada, Takashi Uzu, Hisazumi Araki, Daisuke Koya, Kenzo Kanasaki, Akira Nishiyama, Enyu Imai, Masahiko Ando, Seiichi Matsuo. 51ERA-EDTA CONGRESS. May. 2014. Amsterdam
 31
SPIRONOLACTONE IMPROVING INTRARENAL RENIN-ANGIOTENSIN SYSTEM ACTIVATION IN TYPE II DIABETIC NEPHROPATHY PATIENTS WITH OVERT ALBUMINURIA
Kato Sawako, Maruyama Shoichi, Makino Hiroshi, Wada Jun, Uzu Takashi, Araki Hisazumi, Koya Daisuke, Kanasaki Keizo, Nishiyama Akira, Imai Enyu, Ando Masahiko, Matsuo Seiichi. 2014 Asian Pacific Sosiety /. May. 2014.